Skip to content
Disclosery

EXANE DERIVATIVES: HRI position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on HRI, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 1,197 HRI shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 1,197 shares
    Change vs previous 13F -810 shares

    0.06% of the 13F portfolio, value $107,888.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 2,007 shares
    Change vs previous 13F -1,344 shares

    0.09% of the 13F portfolio, value $335,329.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 3,351 shares
    Change vs previous 13F +92 shares

    0.13% of the 13F portfolio, value $524,580.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 3,259 shares
    Change vs previous 13F +2,228 shares

    0.13% of the 13F portfolio, value $532,697.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 1,031 shares
    Change vs previous 13F -186 shares

    0.03% of the 13F portfolio, value $117,686.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,217 shares
    Change vs previous 13F +232 shares

    0.04% of the 13F portfolio, value $123,313.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 985 shares
    Change vs previous 13F +390 shares

    0.02% of the 13F portfolio, value $65,411.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 595 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $23,567.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).